학술논문
Phase I dose-escalation trial of tucatinib in combination with trastuzumab in patients with HER2-positive breast cancer brain metastases
Document Type
Article
Author
Source
In Annals of Oncology September 2020 31(9):1231-1239
Subject
Language
ISSN
0923-7534